BonelliErede advised Exein and its shareholders; Orrick advised Blue Cloud Ventures; Chiomenti advised HV Capital; White & Case advised J.P. Morgan. Exein, an Italian company specializing...
Exein raises €100 million in a new funding round led by Blue Cloud Ventures
Topline Pro Secures $27 Million Series B Funding to Expand AI Platform for Home Services
Orrick has advised Topline Pro. Topline Pro has announced the closing of a $27 million Series B funding round aimed at further expansion of its AI-native...
Grow Therapy’s $88 Million Funding Round
Orrick, Herrington & Sutcliffe represented Grow Therapy in the transaction. Grow Therapy, a provider-centric tech company improving access to high-quality mental healthcare, has closed an $88...
Third Rock Ventures’ Investment in CARGO Therapeutics
Orrick advised Third Rock Ventures on the deal while Wilson Sonsini represented CARGO Therapeutics. Third Rock Ventures announced its investment in the $200 million Series A financing...
Immunitas Therapeutics’ $58 Million Series B Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Immunitas Therapeutics on the deal. Immunitas Therapeutics, an immuno-oncology biotech company, announced its $58 million Series B financing round. The round...
ImmuneID’s $50 Million Series A Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised ImmuneID on the deal. ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and...
Pyxis Oncology’s $152M Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Pyxis Oncology on the deal. Pyxis Oncology (“Pyxis” or the “Company”) announced the closing of a $152 million...